Laser treatment of erythema and telangiectasia associated with rosacea.Lasers Med Sci. 2002; 17(1):26-33.LM
Abstract
The response of rosacea-associated erythema and telangiectasia to treatment with the pulsed tunable dye laser (PDL) was evaluated in 12 patients. Improvements in erythema, telangiectasia, flushing, the physician's and the patient's perception of overall severity, treatment tolerability, and the adverse side effects were examined. With the sole exception of the patient's assessment of overall severity we have found highly significant improvements in all other parameters evaluated, with excellent tolerance of treatment. We therefore conclude that the PDL is a safe and effective treatment for the erythemato-telangiectatic component of rosacea.
Pub Type(s)
Journal Article
Language
eng
PubMed ID
11845365
Citation
Clark, S M., et al. "Laser Treatment of Erythema and Telangiectasia Associated With Rosacea." Lasers in Medical Science, vol. 17, no. 1, 2002, pp. 26-33.
Clark SM, Lanigan SW, Marks R. Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci. 2002;17(1):26-33.
Clark, S. M., Lanigan, S. W., & Marks, R. (2002). Laser treatment of erythema and telangiectasia associated with rosacea. Lasers in Medical Science, 17(1), 26-33.
Clark SM, Lanigan SW, Marks R. Laser Treatment of Erythema and Telangiectasia Associated With Rosacea. Lasers Med Sci. 2002;17(1):26-33. PubMed PMID: 11845365.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Laser treatment of erythema and telangiectasia associated with rosacea.
AU - Clark,S M,
AU - Lanigan,S W,
AU - Marks,R,
PY - 2002/2/15/pubmed
PY - 2002/4/5/medline
PY - 2002/2/15/entrez
SP - 26
EP - 33
JF - Lasers in medical science
JO - Lasers Med Sci
VL - 17
IS - 1
N2 - The response of rosacea-associated erythema and telangiectasia to treatment with the pulsed tunable dye laser (PDL) was evaluated in 12 patients. Improvements in erythema, telangiectasia, flushing, the physician's and the patient's perception of overall severity, treatment tolerability, and the adverse side effects were examined. With the sole exception of the patient's assessment of overall severity we have found highly significant improvements in all other parameters evaluated, with excellent tolerance of treatment. We therefore conclude that the PDL is a safe and effective treatment for the erythemato-telangiectatic component of rosacea.
SN - 0268-8921
UR - https://www.unboundmedicine.com/medline/citation/11845365/Laser_treatment_of_erythema_and_telangiectasia_associated_with_rosacea_
L2 - https://dx.doi.org/10.1007/s10103-002-8263-8
DB - PRIME
DP - Unbound Medicine
ER -